Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![BiopharmIQ Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::811036897883492352.png) BiopharmIQ by Amp [@BiopharmIQ](/creator/twitter/BiopharmIQ) on x 25.6K followers
Created: 2025-07-15 23:06:29 UTC

$LRMR ✔️
Nomlabofusp (CTI-1601) / Friedreich’s Ataxia / Phase X

» Generally well tolerated

» Dose dependent increases of frataxin levels in tissues tested (skin and buccal cells)

» FXN levels increased to XX% to XX% of the average of the healthy volunteers after OD x XX days dosing

Prior results 📸 👇

7/7

![](https://pbs.twimg.com/media/Gv7v94wWYAAhB6e.jpg)

XXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1945258697317605760/c:line.svg)

**Related Topics**
[$lrmr](/topic/$lrmr)

[Post Link](https://x.com/BiopharmIQ/status/1945258697317605760)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

BiopharmIQ Avatar BiopharmIQ by Amp @BiopharmIQ on x 25.6K followers Created: 2025-07-15 23:06:29 UTC

$LRMR ✔️ Nomlabofusp (CTI-1601) / Friedreich’s Ataxia / Phase X

» Generally well tolerated

» Dose dependent increases of frataxin levels in tissues tested (skin and buccal cells)

» FXN levels increased to XX% to XX% of the average of the healthy volunteers after OD x XX days dosing

Prior results 📸 👇

7/7

XXXXX engagements

Engagements Line Chart

Related Topics $lrmr

Post Link

post/tweet::1945258697317605760
/post/tweet::1945258697317605760